Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
HOMI.BR Stock Summary
Top 10 Correlated ETFs
HOMI.BR
In the News
HOMI.BR Financial details
Company Rating
Neutral
Market Cap
317.37M
Income
-12.59M
Revenue
36.48M
Book val./share
-
Cash/share
-
Dividend
0.15
Dividend %
1.02%
Employees
40
Optionable
No
Shortable
Yes
Earnings
22 May 2024
P/E
-130.86
Forward P/E
14.14
PEG
10.57
P/S
8.24
P/B
0.67
P/C
-
P/FCF
-
Quick Ratio
0.1
Current Ratio
0.15
Debt / Equity
0.91
LT Debt / Equity
0.78
-
-
EPS (TTM)
-0.77
EPS next Y
1.17
EPS next Q
-
EPS this Y
-123.6%
EPS next Y
-252.5%
EPS next 5Y
-257.06%
EPS last 5Y
NAN%
Revenue last 5Y
6.71%
Revenue Q/Q
5812.01%
EPS Q/Q
-
-
-
-
-
SMA20
6.67%
SMA50
6.67%
SMA100
14.29%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
100%
Oper. Margin
10%
Profit Margin
-6%
Payout
-
Shs Outstand
19.62M
Shs Float
11.46M
-
-
-
-
Target Price
-
52W Range
13.2-21.25
52W High
-21.24%
52W Low
+27.23%
RSI
65
Rel Volume
0.73
Avg Volume
9.8K
Volume
7.14K
Perf Week
4.95%
Perf Month
9.1%
Perf Quarter
10.86%
Perf Half Y
4.16%
-
-
-
-
Beta
0.176
-
-
Volatility
0.18%, 0.56%
Prev Close
0.98%
Price
16.54
Change
-1.19%
HOMI.BR Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.59 | 1.69 | 1.77 | 1.9 | 1.94 | |
Net income per share | 3.38 | 1.15 | 2.97 | 3.35 | -0.76 | |
Operating cash flow per share | 0.9 | 1.03 | 1.12 | 1.45 | 0 | |
Free cash flow per share | 0.65 | 0.72 | -0.1 | -0.49 | 0 | |
Cash per share | 0.14 | 0.18 | 0.14 | -1.59 | 0.16 | |
Book value per share | 18.83 | 18.87 | 20.86 | 23.97 | 22.34 | |
Tangible book value per share | 18.81 | 18.85 | 20.83 | 23.94 | 22.34 | |
Share holders equity per share | 18.83 | 18.87 | 20.86 | 23.97 | 22.34 | |
Interest debt per share | 19.24 | 20.1 | 23.43 | 23.12 | 20.51 | |
Market cap | 374.85M | 379.78M | 401.15M | 372.84M | 289.88M | |
Enterprise value | 683.94M | 703.42M | 778.73M | 759.19M | 665.68M | |
P/E ratio | 6.76 | 20.11 | 8.21 | 6.51 | -20.3 | |
Price to sales ratio | 14.32 | 13.64 | 13.76 | 11.45 | 8 | |
POCF ratio | 25.41 | 22.36 | 21.7 | 14.99 | 0 | |
PFCF ratio | 35.26 | 31.94 | -247.47 | -44.59 | 0 | |
P/B Ratio | 1.21 | 1.22 | 1.17 | 0.91 | 0.69 | |
PTB ratio | 1.21 | 1.22 | 1.17 | 0.91 | 0.69 | |
EV to sales | 26.12 | 25.27 | 26.71 | 23.32 | 18.38 | |
Enterprise value over EBITDA | 10.44 | 25.58 | 15.71 | 24.78 | 45.66 | |
EV to operating cash flow | 46.36 | 41.41 | 42.13 | 30.52 | 0 | |
EV to free cash flow | 64.33 | 59.16 | -480.4 | -90.79 | 0 | |
Earnings yield | 0.15 | 0.05 | 0.12 | 0.15 | -0.05 | |
Free cash flow yield | 0.03 | 0.03 | 0 | -0.02 | 0 | |
Debt to equity | 1.01 | 1.05 | 1.11 | 0.95 | 0.91 | |
Debt to assets | 0.49 | 0.5 | 0.52 | 0.48 | 0.47 | |
Net debt to EBITDA | 4.72 | 11.77 | 7.62 | 12.61 | 25.78 | |
Current ratio | 0.12 | 0.17 | 0.18 | 0.19 | 0 | |
Interest coverage | 21.35 | 7.28 | 13.43 | 5.45 | 2.67 | |
Income quality | 0.23 | 0.68 | 0.39 | 0.95 | 0 | |
Dividend Yield | 0.04 | 0.05 | 0.04 | 0.05 | 0 | |
Payout ratio | 0.27 | 0.97 | 0.33 | 0.3 | 0 | |
Sales general and administrative to revenue | 0.2 | 0.18 | 0.15 | 0.16 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.28 | -0.3 | -1.09 | -1.34 | 0 | |
Capex to revenue | -0.16 | -0.18 | -0.69 | -1.02 | 0 | |
Capex to depreciation | -20.9 | -24.03 | -101.55 | -92.57 | 0 | |
Stock based compensation to revenue | 0.03 | 0 | -0.02 | 0.04 | 0 | |
Graham number | 37.82 | 22.08 | 37.35 | 42.48 | 19.59 | |
ROIC | 0.1 | 0.04 | 0.06 | 0.03 | 0.02 | |
Return on tangible assets | 0.09 | 0.03 | 0.07 | 0.07 | -0.02 | |
Graham Net | -19.83 | -20.58 | -23.67 | -24.99 | -20.62 | |
Working capital | -42.26M | -31.92M | -38.29M | -35.12M | -51.8M | |
Tangible asset value | 309.24M | 309.89M | 342.46M | 409.49M | 417.76M | |
Net current asset value | -323.81M | -337.1M | -385.44M | -394.27M | -390.05M | |
Invested capital | 1.01 | 1.05 | 1.11 | 0.95 | 0.91 | |
Average receivables | 905.97K | 2.41M | 3.16M | 2.73M | 2.01M | |
Average payables | 2.71M | 3.1M | 2.23M | 2.12M | 1.49M | |
Average inventory | -147.02K | -366 | 146.66K | 270K | 270K | |
Days sales outstanding | 25.26 | 39.52 | 41.33 | 24.12 | 18.88 | |
Days payables outstanding | 247.31 | 253.03 | 93.87 | 232.12 | 0 | |
Days of inventory on hand | -24.29 | 23.13 | 0 | 41.96 | 0 | |
Receivables turnover | 14.45 | 9.24 | 8.83 | 15.13 | 19.33 | |
Payables turnover | 1.48 | 1.44 | 3.89 | 1.57 | 0 | |
Inventory turnover | -15.03 | 15.78 | 0 | 8.7 | 0 | |
ROE | 0.18 | 0.06 | 0.14 | 0.14 | -0.03 | |
Capex per share | -0.25 | -0.31 | -1.22 | -1.94 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.94 | 0.48 | 0.53 | 0 | 0 | |
Net income per share | 0.51 | -0.5 | -0.22 | 0 | 0 | |
Operating cash flow per share | 0.47 | 0.37 | 0.59 | 0 | 0 | |
Free cash flow per share | 0.47 | 0.37 | 0.59 | 0 | 0 | |
Cash per share | -1.53 | 0.48 | 0.48 | 0 | 0 | |
Book value per share | 23.06 | 5.61 | 22.07 | 0 | 0 | |
Tangible book value per share | 23.02 | 22.06 | 22.04 | 0 | 0 | |
Share holders equity per share | 23.06 | 5.61 | 22.07 | 0 | 0 | |
Interest debt per share | 22.01 | 18.72 | 22.92 | 0 | 0 | |
Market cap | 387.64M | 366.92M | 286.64M | 0 | 0 | |
Enterprise value | 773.99M | 358.43M | 684.81M | 0 | 375.8M | |
P/E ratio | 10.7 | -10.33 | -18.48 | 0 | 0 | |
Price to sales ratio | 23.26 | 43.01 | 30.39 | 0 | 0 | |
POCF ratio | 45.99 | 55.62 | 27.15 | 0 | 0 | |
PFCF ratio | 46.32 | 55.62 | 27.5 | 0 | 0 | |
P/B Ratio | 0.95 | 3.68 | 0.73 | 0 | 0 | |
PTB ratio | 0.95 | 3.68 | 0.73 | 0 | 0 | |
EV to sales | 46.45 | 42.01 | 72.6 | 0 | 20.64 | |
Enterprise value over EBITDA | 77.89 | -70.11 | -245.54 | 0 | 75.01 | |
EV to operating cash flow | 91.82 | 54.33 | 64.86 | 0 | 0 | |
EV to free cash flow | 92.49 | 54.33 | 65.71 | 0 | 0 | |
Earnings yield | 0.02 | -0.02 | -0.01 | 0 | 0 | |
Free cash flow yield | 0.02 | 0.02 | 0.04 | 0 | 0 | |
Debt to equity | 0.95 | 3.33 | 1.03 | 0 | 0.91 | |
Debt to assets | 0.48 | 0.41 | 0.5 | 0 | 0.47 | |
Net debt to EBITDA | 38.88 | 1.66 | -142.77 | 0 | 75.01 | |
Current ratio | 0.19 | 0.15 | 0.15 | 0 | 0 | |
Interest coverage | 10.4 | -4.45 | -2.16 | 2.1 | 2.07 | |
Income quality | 0.31 | -1.03 | -0.83 | 0 | 0 | |
Dividend Yield | 0.04 | 0 | 0.01 | 0 | 0 | |
Payout ratio | 1.67 | -0.15 | -0.69 | 0 | 0 | |
Sales general and administrative to revenue | 0.04 | 0.11 | 0.1 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.01 | 0 | -0.01 | 0 | 0 | |
Capex to revenue | 0 | 0 | -0.01 | 0 | 0 | |
Capex to depreciation | -0.32 | 0 | -0.73 | 0 | 0 | |
Stock based compensation to revenue | -0.08 | 0 | 0 | 0 | 0 | |
Graham number | 16.26 | 7.93 | 10.4 | 0 | 0 | |
ROIC | 0.01 | -0.01 | 0 | 0 | 0.01 | |
Return on tangible assets | 0.01 | -0.01 | 0 | 0 | 0 | |
Graham Net | -24.04 | -23.27 | -23.07 | 0 | 0 | |
Working capital | -35.12M | -74.82M | -74.81M | 0 | -51.8M | |
Tangible asset value | 409.49M | 392.35M | 392.35M | 0 | 417.76M | |
Net current asset value | -394.27M | -408.75M | -408.75M | 0 | -390.05M | |
Invested capital | 0.95 | 3.33 | 1.03 | 0 | 0.91 | |
Average receivables | 1.08M | 1.08M | 1.23M | 0 | 0 | |
Average payables | 2.99M | 2.33M | 5.28M | 0 | 0 | |
Average inventory | 270K | 270K | 1.35M | 0 | 0 | |
Days sales outstanding | 11.62 | 0 | 23.49 | 0 | 9.26 | |
Days payables outstanding | 95.67 | 55.2 | 146.88 | 0 | 0 | |
Days of inventory on hand | 17.3 | 0 | 44.43 | 0 | 0 | |
Receivables turnover | 7.75 | 0 | 3.83 | 0 | 9.72 | |
Payables turnover | 0.94 | 1.63 | 0.61 | 0 | 0 | |
Inventory turnover | 5.2 | 0 | 2.03 | 0 | 0 | |
ROE | 0.02 | -0.09 | -0.01 | 0 | 0 | |
Capex per share | 0 | 0 | -0.01 | 0 | 0 |
HOMI.BR Frequently Asked Questions
What is Home Invest Belgium S.A. stock symbol ?
Home Invest Belgium S.A. is a BE stock and trading under the symbol HOMI.BR
What is Home Invest Belgium S.A. stock quote today ?
Home Invest Belgium S.A. stock price is $16.54 today.
Is Home Invest Belgium S.A. stock public?
Yes, Home Invest Belgium S.A. is a publicly traded company.